Kanamic Network Co Ltd
Kanamic Network Co Ltd provides healthcare technology solutions, primarily generating revenue through services and equipment related to healthcare facilities and biotechnology.
Business. Kanamic Network Co Ltd (3939.T) is a healthcare services and equipment company primarily engaged in biotechnology activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in Japan, the company is listed on the Tokyo Stock Exchange. Specific operating segments and geographic breakdowns are not disclosed in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Kanamic Network Co Ltd (3939.T) is a healthcare services and equipment company primarily engaged in biotechnology activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in Japan, the company is listed on the Tokyo Stock Exchange. Specific operating segments and geographic breakdowns are not disclosed in the available data.
Kanamic Network Co Ltd maintains a strong liquidity position, with a current ratio of 2.76 and a significant cash and equivalents balance of 3,327,111,000 JPY, indicating robust short-term financial health. The company's price-to-book ratio of 5.03 and price-to-tangible-book ratio of 5.03 suggest that the market values the company's equity at a premium relative to its book value.
In terms of profitability, Kanamic Network Co Ltd demonstrates a return on equity of 23.91% and a return on assets of 16.99%, which are strong indicators of efficient use of equity and assets to generate profit. The company's operating income of 1,599,942,000 JPY and net income of 1,111,529,000 JPY reflect solid operational performance.
The company's revenue is concentrated in the healthcare technology segment, with no disclosed geographic diversification, suggesting a potential concentration risk in both product and geographic markets. The company's growth trajectory is supported by a mean revenue estimate of 6,350,000,000 JPY, indicating a projected increase from the last actual revenue of 5,500,000,000 JPY.
Kanamic Network Co Ltd faces low liquidity and dilution risks, with no immediate filing-based flags detected. The company's debt-to-equity ratio of 0.14 indicates a conservative capital structure with minimal leverage. The company's capital expenditure of -378,698,000 JPY suggests a reduction in capital spending, which may be a strategic move to preserve cash.
Recent events, including analyst estimates and financial performance, indicate a positive outlook for the company. The mean EPS estimate of 29.10 JPY is higher than the last actual EPS of 23.42 JPY, suggesting optimism among analysts regarding the company's earnings potential.
- Kanamic Network Co Ltd has a strong liquidity position with a current ratio of 2.76 and significant cash reserves.
- The company's return on equity of 23.91% and return on assets of 16.99% indicate efficient use of equity and assets.
- The company's revenue is concentrated in the healthcare technology segment, with no disclosed geographic diversification.
- Analysts project a revenue increase to 6,350,000,000 JPY, suggesting a positive growth trajectory.
- Kanamic Network Co Ltd faces low liquidity and dilution risks, with a conservative capital structure.
- "margin_outlook_rationale": "The company's gross profit of 3,536,422,000 JPY and operating income of 1,599,942,000 JPY indicate strong margin performance, supported by efficient cost management.",
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 29,10 |
| Revenue | —no estimate | —no estimate | 6,3B JPY |
| Operating income | —no estimate | —no estimate | —no estimate |
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Kanamic Network Co Ltd Market data — financials · 2026-05-26
- Kanamic Network Co Ltd Market data — analyst estimates · 2026-05-26